ArticleCancer immunology research2025

Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy.

Yingqin Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.